for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-UK's CMA Invites Comments On Dechra Pharmaceuticals, Elanco Animal Health

March 26 (Reuters) -

* UK’S CMA INVITES COMMENTS ON ANTICIPATED ACQUISITION BY DECHRA PHARMACEUTICALS PLC OF OSURNIA BUSINESS OF ELANCO ANIMAL HEALTH INCORPORATED

* THE COMPETITION AND MARKETS AUTHORITY (CMA) IS CONSIDERING WHETHER A DEAL WOULD CREATE A MERGER SITUATION, LEAD TO A SUBSTANTIAL LESSENING OF COMPETITION WITHIN ANY UK MARKET. Source text for Eikon: Further company coverage: [ ] (Reporting By Simon Jessop)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up